Quantitative evaluation of oculomotor disturbances in progressive supranuclear palsy


Por: Pagonabarraga, J, Horta-Barba, A, Busteed, L, Bejr-Kasem, H, Illan-Gala, I, Aracil-Bolanos, I, Marin-Lahoz, J, Pascual-Sedano, B, Perez, J, Campolongo, A, Izquierdo, C, Martinez-Horta, S, Sampedro, F, Kulisevsky, J

Publicada: 1 abr 2021 Ahead of Print: 1 mar 2021
Resumen:
Objectives: To explore and quantify systematically the ocular abnormal movements present in progressive supranuclear palsy (PSP) from the early stages, to assess the ability of this standardized examination in the differential diagnosis of PSP from Parkinson's disease (PD), and to compare in more detail oculomotor disturbances between PSP variants. Methods: Sixty-five consecutive PSP patients with <5 years of disease duration diagnosed according to MDS-PSP criteria, 25 PD patients and 25 controls comparable in age, education and disease duration were explored using a bedside battery of tests for the quantitative evaluation of oculomotor dysfunction in clinical practice. Other accepted scales were used for measurement of motor (PSPRS), cognitive (FAB) and behavioral (FBI) impairment. Results: Measurement of oculomotor dysfunction significantly differentiated PSP from PD and controls (p < 0.001) and showed high accuracy in the differential diagnosis of early-to-mid stage PSP from PD. PSPParkinsonism and PSP-Progressive Gait Freezing phenotypes showed more preserved ocular motor function compared to PSP-Richardson Syndrome, although no differences were found between PSP subtypes in the number of square wave jerks, optokinetic nystagmus defects, degree of apraxia of eyelid opening, or presence of the "Round the Houses" sign. Conclusions: Using a bedside clinical instrument for quantifying oculomotor disturbances in PSP shows promising potential at differentiating PSP from PD, and it seems able to provide a qualitative and quantitative description of ocular motor function in parkinsonian disorders.

Filiaciones:
Pagonabarraga, J:
 Hosp Santa Creu & Sant Pau, Dept Neurol, Movement Disorders Unit, Barcelona, Spain

 Biomed Res Inst IIB St Pau, Barcelona, Spain

 Univ Autonoma Barcelona, Bellaterra, Spain

Horta-Barba, A:
 Hosp Santa Creu & Sant Pau, Dept Neurol, Movement Disorders Unit, Barcelona, Spain

 Biomed Res Inst IIB St Pau, Barcelona, Spain

 Univ Autonoma Barcelona, Bellaterra, Spain

Busteed, L:
 Hosp Santa Creu & Sant Pau, Dept Neurol, Movement Disorders Unit, Barcelona, Spain

 Biomed Res Inst IIB St Pau, Barcelona, Spain

 Univ Autonoma Barcelona, Bellaterra, Spain

Bejr-Kasem, H:
 Hosp Santa Creu & Sant Pau, Dept Neurol, Movement Disorders Unit, Barcelona, Spain

 Biomed Res Inst IIB St Pau, Barcelona, Spain

 Univ Autonoma Barcelona, Bellaterra, Spain

Illan-Gala, I:
 Hosp Santa Creu & Sant Pau, Dept Neurol, Movement Disorders Unit, Barcelona, Spain

 Biomed Res Inst IIB St Pau, Barcelona, Spain

 Univ Autonoma Barcelona, Bellaterra, Spain

 Ctr Invest Red Enfermedades Neurodegenerat CIBERN, Madrid, Spain

 Hosp Santa Creu & Sant Pau, Neurol Dept, St Pau Memory Unit, Barcelona, Spain

Aracil-Bolanos, I:
 Hosp Santa Creu & Sant Pau, Dept Neurol, Movement Disorders Unit, Barcelona, Spain

 Biomed Res Inst IIB St Pau, Barcelona, Spain

 Univ Autonoma Barcelona, Bellaterra, Spain

Marin-Lahoz, J:
 Hosp Santa Creu & Sant Pau, Dept Neurol, Movement Disorders Unit, Barcelona, Spain

 Biomed Res Inst IIB St Pau, Barcelona, Spain

 Univ Autonoma Barcelona, Bellaterra, Spain

Pascual-Sedano, B:
 Hosp Santa Creu & Sant Pau, Dept Neurol, Movement Disorders Unit, Barcelona, Spain

 Biomed Res Inst IIB St Pau, Barcelona, Spain

 Univ Autonoma Barcelona, Bellaterra, Spain

Perez, J:
 Hosp Santa Creu & Sant Pau, Dept Neurol, Movement Disorders Unit, Barcelona, Spain

 Biomed Res Inst IIB St Pau, Barcelona, Spain

 Univ Autonoma Barcelona, Bellaterra, Spain

Campolongo, A:
 Hosp Santa Creu & Sant Pau, Dept Neurol, Movement Disorders Unit, Barcelona, Spain

 Biomed Res Inst IIB St Pau, Barcelona, Spain

 Univ Autonoma Barcelona, Bellaterra, Spain

Izquierdo, C:
 Hosp Santa Creu & Sant Pau, Dept Neurol, Movement Disorders Unit, Barcelona, Spain

 Biomed Res Inst IIB St Pau, Barcelona, Spain

 Univ Autonoma Barcelona, Bellaterra, Spain

Martinez-Horta, S:
 Hosp Santa Creu & Sant Pau, Dept Neurol, Movement Disorders Unit, Barcelona, Spain

 Biomed Res Inst IIB St Pau, Barcelona, Spain

 Univ Autonoma Barcelona, Bellaterra, Spain

Sampedro, F:
 Hosp Santa Creu & Sant Pau, Dept Neurol, Movement Disorders Unit, Barcelona, Spain

 Biomed Res Inst IIB St Pau, Barcelona, Spain

 Univ Autonoma Barcelona, Bellaterra, Spain

Kulisevsky, J:
 Hosp Santa Creu & Sant Pau, Dept Neurol, Movement Disorders Unit, Barcelona, Spain

 Biomed Res Inst IIB St Pau, Barcelona, Spain

 Univ Autonoma Barcelona, Bellaterra, Spain
ISSN: 13538020





PARKINSONISM & RELATED DISORDERS
Editorial
ELSEVIER SCI LTD, THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND, Reino Unido
Tipo de documento: Article
Volumen: 85 Número:
Páginas: 63-68
WOS Id: 000651614000014
ID de PubMed: 33744691

MÉTRICAS